For research use only. We do not sell to patients.
URMC-099
CAS No. : 1229582-33-5
Biological Activity：URMC-099 is an orally bioavailable and potent mixed lineage kinase type 3 (MLK3) (IC50=14 nM) inhibitor with with excellent blood-brain barrier penetration properties.
Research Area：Neurological Disease|Cancer
Targets：Autophagy|Mixed Lineage Kinase
Related Screening Libraries:Bioactive Compound Library Plus;Immunology/Inflammation Compound Library;Kinase Inhibitor Library;MAPK Compound Library;Anti-Cancer Compound Library;CNS-Penetrant Compound Library;Autophagy Compound Library;Oxygen Sensing Compound Library;Orally Active Compound Library;Anti-Breast Cancer Compound Library;Anti-Obesity Compound Library;
Related Small Molecules:MLKL-IN-1;TC13172;MLKL-IN-2;NecroIr1;Necrosulfonamide;MLKL-IN-3;MLK-IN-1;RIP1/RIP3/MLKL activator 1;GW806742X;NecroIr2;MLKL-IN-4;Necrosulfonamide-d4
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
